Paper17549390
DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK and 6 others. Int J Mol Med, 2007. Cited by 164 papers, by iCite.
Cite this record
ConductScience Library. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Papers, record 17549390. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17549390
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| DNA (Cytosine-5-)-Methyltransferases | Major topic |
| DNA Methylation | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Liver Neoplasms | Major topic |
| Genes, Tumor Suppressor | |
| Humans | |
| Liver | |
| RNA, Messenger | |
| Reverse Transcriptase Polymerase Chain Reaction |
Source PubMed
Cited by116
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42878936 | Cell-free DNA methylation markers in the diagnosis of hepatitis B virus-related- hepatocellular carcinoma: a review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42878936 | PubMed |
| 42512290 | Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms and Biomarkers for Precision Therapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512290 | PubMed |
| 42488830 | Compatibility mechanism of Chrysanthemi Indici Flos compound against hepatocellular carcinoma based on balance of DNMTs/TET2. | Chin Herb Med | 2026 | https://conductscience.org/library/papers/42488830 | PubMed |
| 42304060 | A 5mC-related gene signature predicts prognosis and therapy response in hepatocellular carcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/42304060 | PubMed |
| 42288694 | Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities. | Cancer Gene Ther | 2026 | https://conductscience.org/library/papers/42288694 | PubMed |
| 41987339 | DNMT3A in cancer: from epigenetic writer to oncogenic driver. | Clin Epigenetics | 2026 | https://conductscience.org/library/papers/41987339 | PubMed |
| 41465346 | Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465346 | PubMed |
| 41301491 | Rewriting the Fate of Cancer: Epigenetic and Epitranscriptomic Regulators in the Metastatic Cascade. | Biomolecules | 2025 | https://conductscience.org/library/papers/41301491 | PubMed |
| 40323963 | DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation. | PLoS One | 2025 | https://conductscience.org/library/papers/40323963 | PubMed |
| 40084815 | Insight into the role of DNA methylation in prognosis and treatment response prediction of gastrointestinal cancers. | Epigenomics | 2025 | https://conductscience.org/library/papers/40084815 | PubMed |
| 39905966 | Structure-Activity Relationship Studies of DNA Methyltransferase 1 Monovalent Degraders. | J Med Chem | 2025 | https://conductscience.org/library/papers/39905966 | PubMed |
| 39638815 | Antimicrobial activity and cytotoxic and epigenetic effects of tannic acid-loaded chitosan nanoparticles. | Sci Rep | 2024 | https://conductscience.org/library/papers/39638815 | PubMed |
| 39493259 | An overview of risk assessment and monitoring of malignant transformation in cirrhotic nodules. | Ther Adv Gastroenterol | 2024 | https://conductscience.org/library/papers/39493259 | PubMed |
| 39462685 | Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/39462685 | PubMed |
| 38920644 | Pirfenidone Reverts Global DNA Hypomethylation, Promoting DNMT1/UHRF/PCNA Coupling Complex in Experimental Hepatocarcinoma. | Cells | 2024 | https://conductscience.org/library/papers/38920644 | PubMed |
| 38528605 | Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinoma. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38528605 | PubMed |
| 37964494 | The efficacy of sorafenib against hepatocellular carcinoma is enhanced by 5-aza-mediated inhibition of ID1 promoter methylation. | FEBS Open Bio | 2024 | https://conductscience.org/library/papers/37964494 | PubMed |
| 37726886 | Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. | Cell Adh Migr | 2023 | https://conductscience.org/library/papers/37726886 | PubMed |
| 37628829 | Insights into the Inhibitory Mechanisms of the Covalent Drugs for DNMT3A. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628829 | PubMed |
| 36968013 | Unveiling the methyl transfer mechanisms in the epigenetic machinery DNMT3A-3 L: A comprehensive study integrating assembly dynamics with catalytic reactions. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/36968013 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| CDKN2B | 1030 | PubTator's text mining | https://conductscience.org/library/genes/1030 | NCBI Gene |
| DNMT1 | 1786 | PubTator's text mining | https://conductscience.org/library/genes/1786 | NCBI Gene |
| DNMT3A | 1788 | PubTator's text mining | https://conductscience.org/library/genes/1788 | NCBI Gene |
| DNMT3B | 1789 | PubTator's text mining | https://conductscience.org/library/genes/1789 | NCBI Gene |
| HIC1 | 3090 | PubTator's text mining | https://conductscience.org/library/genes/3090 | NCBI Gene |
| RASSF1 | 11186 | PubTator's text mining | https://conductscience.org/library/genes/11186 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17549390
GET https://conductscience.org/api/papers/v1/17549390/cited_by?page=2